PREDICTING THE EFFECTS OF CYP2C19 AND CARBOXYLESTERASES ON VICAGREL, A NOVEL P2Y12 ANTAGONIST, BY PHYSIOLOGICALLY BASED PHARMACOKINETIC/PHARMACODYNAMIC MODELING APPROACH

Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach

Vicagrel, a novel acetate derivative of clopidogrel, exhibits a favorable safety profile and excellent antiplatelet activity.Studies aim at identifying genetic and non-genetic factors affecting vicagrel metabolic enzymes here Cytochrome P450 2C19 (CYP2C19), Carboxylesterase (CES) 1 and 2 (CES1 and CES2), which may potentially lead to altered pharma

read more

Missense mutation in the second RNA binding domain reveals a role for Prkra (PACT/RAX) during skull development.

Random chemical mutagenesis of the mouse genome can causally connect genes to specific phenotypes.Using this approach, reduced pinna (rep) or microtia, a defect in ear development, was mapped to a small region of mouse chromosome 2.Sequencing argan oil pure purple of this region established co-segregation of the phenotype (rep) with a mutation in t

read more